A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

NCT07222969 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: VIB305 for Injection

Sponsor

Vibrant Sciences Limited